Dr. Tsuji received his MD and PhD from The University of Tokyo. He served his residency in Neurology at Jichi Medical School. In 1984, he moved to NIH and elucidated molecular basis of Gaucher disease. In 1987 he moved to Niigata University, Japan and was appointed as Professor of Neurology and Director at Brain Research Institute, Niigata University. In 2002, he moved to The University of Tokyo as Professor and Chair of Department of Neurology in 2002. His research focus is elucidation of molecular basis of hereditary as well as sporadic neurological diseases based on comprehensive genome analysis. In 2013, his team discovered that COQ2 gene is a susceptibility gene for multiple system atrophy (MSA), which suggested the efficacy of supplementation of a high dose CoQ10 for MSA. He has started a phase 2 clinical trial for MSA this year. Very recently his team discovered noncoding repeat expansions in benign adult familial myoclonus epilepsy (BAFME).
1981 Associate in Neurology, Jichi Medical School.
1984 Visiting Fellow, National Institutes of Health
1991 Professor and Chair, Department of Neurology, Brain research Institute, Niigata University
2001 Director, Brain Research Institute, Niigata University
2002 Professor and Chair, Department of Neurology, The University of Tokyo
2018 Professor, International University of Health and Welfare
2018 Director, Institute of Medical Genomics, International University of Health and Welfare
2018 Project Professor, Department of Molecular Neurology, The University of Tokyo